AFS Financial Group’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-823
Closed -$442K 86
2023
Q3
$442K Sell
823
-71
-8% -$36.6K 0.3% 57
2023
Q2
$419K Sell
894
-56
-6% -$23.5K 0.27% 62
2023
Q1
$326K Buy
950
+150
+19% +$50.6K 0.22% 73
2022
Q4
$293K Buy
+800
New +$284K 0.21% 77

Other funds holding LLY

AFS Financial Group's LLY Position: Q4 2023 in Review

AFS Financial Group sold out of Eli Lilly (LLY) in Q4 2023, closing a stake of 823 shares — an estimated $442K sold.

AFS Financial Group first reported a position in LLY in Q4 2022 and held it in 4 quarters. The position peaked at $442K in Q3 2023. 3,272 funds tracked by Wall St. Rank hold LLY as of Q4 2023.

  • AFS Financial Group reported no remaining Eli Lilly position as of Q4 2023 after selling out during the quarter.
  • AFS Financial Group sold 823 Eli Lilly shares in Q4 2023, an estimated $442K.
  • AFS Financial Group first reported a position in Eli Lilly in Q4 2022 and held it in 4 quarters.
  • AFS Financial Group's Eli Lilly position peaked at $442K in Q3 2023.
  • 3,272 funds tracked by Wall St. Rank held Eli Lilly as of Q4 2023.

Based on AFS Financial Group's 13F filing for Q4 2023, filed 23 Jan 2024.